Articles liés à Obesity and Breast Cancer: The Role of Dysregulated...
Synopsis
This book discusses the connection between obesity and breast cancer in older women. It explores the application of novel therapies to inhibit aromatase in the breast.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
À propos de l?auteur
Kristy A. Brown, Ph.D., is a NHMRC Career Development Fellow and Co-Head of the Metabolism and Cancer Group at Prince Henry's Institute. Dr. Brown is also an Adjunct Lecturer of Physiology at Monash University. Dr Brown's area of research interest is the regulation of the aromatase gene in the context of obesity and breast cancer.
Evan Simpson, Ph.D., is a Senior Principal Research Fellow and Co-Head of the Metabolism and Cancer group at Prince Henry's Institute. He is also an Honorary Professor for the Department of Biochemistry and Molecular Biology and Monash University. Dr. Simpson is the Laboratory Director of the Victorian Breast Cancer Research Consortium. This consortium involves eight medical research institutes and was established in 1997 to conduct world class research into breast cancer. Dr. Simpson's work also led to the creation of the first aromatase knockout (ArKO) mouse, which is a model of oestrogen insufficiency that compares with the phenotype of humans with natural mutations in aromatase. His current research is focused on the role of oestrogen in several important health conditions, including obesity, diabetes, osteoporosis and of course, breast cancer.Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Acheter neuf
Afficher cet article
EUR 48,36
EUR 6,81 expédition vers Etats-Unis
Destinations, frais et délaisAutres éditions populaires du même titre
Résultats de recherche pour Obesity and Breast Cancer: The Role of Dysregulated...
Image d'archives
Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)
Vendeur : Best Price, Torrance, CA, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. SUPER FAST SHIPPING. N° de réf. du vendeur 9781489980014
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Obesity and Breast Cancer : The Role of Dysregulated Estrogen Metabolism
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 20390975-n
Quantité disponible : Plus de 20 disponibles
Image d'archives
Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur ABLIING23Mar2716030158580
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (Paperback or Softback)
Edité par
Springer 11/21/2013, 2013
ISBN 10 : 1489980016
ISBN 13 : 9781489980014
Neuf
Paperback or Softback
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Paperback or Softback. Etat : New. Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism 0.25. Book. N° de réf. du vendeur BBS-9781489980014
Quantité disponible : 5 disponible(s)
Image d'archives
Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)
Vendeur : California Books, Miami, FL, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur I-9781489980014
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Obesity and Breast Cancer : The Role of Dysregulated Estrogen Metabolism
Edité par
Springer, 2013
ISBN 10 : 1489980016
ISBN 13 : 9781489980014
Ancien ou d'occasion
Couverture souple
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Évaluation du vendeur 5 sur 5 étoiles
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 20390975
Quantité disponible : Plus de 20 disponibles
Image d'archives
Obesity and Breast Cancer: The Role of Dysregulated Estrogen Metabolism (SpringerBriefs in Cancer Research)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. In. N° de réf. du vendeur ria9781489980014_new
Quantité disponible : Plus de 20 disponibles
Image d'archives
Obesity and Breast Cancer : The Role of Dysregulated Estrogen Metabolism
Vendeur : Chiron Media, Wallingford, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
PF. Etat : New. N° de réf. du vendeur 6666-IUK-9781489980014
Quantité disponible : 10 disponible(s)
Image fournie par le vendeur
Obesity and Breast Cancer : The Role of Dysregulated Estrogen Metabolism
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. N° de réf. du vendeur 20390975-n
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Obesity and Breast Cancer
Edité par
Springer New York Nov 2013, 2013
ISBN 10 : 1489980016
ISBN 13 : 9781489980014
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Obesity is a risk factor for breast cancer in older women. A number of adipose-derived and obesity-related factors have been shown to affect tumour cell growth. These include adipokines, insulin, IGF-1 and oestrogens. The majority of obesity-related postmenopausal breast cancers are oestrogen-dependent. Since the ovaries no longer produce oestrogens after menopause, and that circulating levels are negligible, it is evident that it is the oestrogens produced locally within the breast adipose that are responsible for the increased growth of breast cancer cells. Aromatase is the enzyme that converts androgens into oestrogens and its regulation is dependent on the activity of a number of tissue-specific promoters. Targeting oestrogen biosynthesis in obesity may be useful for the prevention of breast cancer. Aromatase inhibitors are efficacious at treating postmenopausal breast cancer and recent studies suggest that they may also be useful in the prevention setting. However, these compounds inhibit the catalytic activity of aromatase and as a consequence lead to a number of undesirable side-effects, including arthralgia and possible cognitive defects due to inhibition of aromatase in the bone and brain, respectively. Novel therapies, such as those employed to treat obesity-associated disease, including anti-diabetics, may prove successful at inhibiting aromatase specifically within the breast. This SpringerBrief will explore all of these issues in depth and the authors are in a unique position to write about this topic, having extensive experience in the field of aromatase research. 68 pp. Englisch. N° de réf. du vendeur 9781489980014
Quantité disponible : 2 disponible(s)